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Amino acid losses during hemodialysis with infusion of amino acids and
glucose. This study evaluated the effects during hemodialysis of intrave-
nous infusion of amino acids and glucose on plasma amino acid and
glucose concentrations and amino acid losses. Eight men undergoing
maintenance hemodialysis were each studied during two dialyses using
glucose-free dialysate. During one hemodialysis, they were infused with
800 ml of normal saline. During the other hemodialysis, they were
infused with an equal volume of water which contained 39.5 g of
essential and non-essential free L-amino acids and 200 g of d-glucose.
The solutions were infused throughout the dialysis procedure into the
drip chamber of the venous outflow from the dialyzer. Subjects were
fasted from the night before until the end of hemodialysis, and the order
of administration of the two solutions was determined randomly.
Plasma essential, non-essential, and total amino acids fell significantly
during the infusion of normal saline and rose during the administration
of amino acids and glucose. Dialysate total-free amino acid losses
averaged 8.2 3.1 SD g during the infusion of normal saline and 12.6
3.6 g with the administration of amino acids and glucose. These findings
indicate that the intravenous infusion of amino acids and glucose during
hemodialysis prevents a fall in plasma amino acid and glucose concen-
trations and leads to only a slight increase in the losses of free amino
acids into dialysate. Because most of the infused amino acids are
retained, this technique may be used during hemodialysis to avoid a net
outflow of amino acids, minimize disruption of amino acid and glucose
pools, and provide a nutritional supplement.
Pertes en amino-acides au cours de l'hémodialyse avec perfusion
d'acides aminés et de glucose. Cette étude a permis d'évaluer les effets
de Ia perfusion intraveineuse d'acides aminés et de glucose pendant
l'hémodialyse sur les concentrations plasmatiques d'acides aminés et
de glucose, et les pertes d'acides aminés. Huit hommes en hémodialyse
chronique ont chacun été étudiés pendant deux dialyses avec un
dialysat sans glucose. Pendant une des dialyses ils étaient perfusés avec
800 ml de solute physiologique. Pendant l'hemodialyse autre ils ont
infuse avec un égal volume d'eau contenant 39,5 g de L-acides aminés
libres essentiels ou non, et 200 g de d-glucose. Les solutions étaient
perfusees pendant Ia dialyse dans Ia tubulure veineuse venant du
dialyseur. Les malades étaient ajeün la nuit précédante etjuSqu'à Ia fin
de Ia dialyse, et l'ordre d'administration des deux solutions était
déterminé au hasard. Les acides aminés plasmatiques totaux, essentiels
et non essentiels ont significativement diminué pendant Ia perfusion de
solute physiologique, et se sont élevés pendant l'administration d'a-
cides aminés et de glucose. Dans le dialysat, les pertes totales d'acides
aminés libres étaient en moyenne de 8,2 3,1 g (ds) pendant Ia
perfusion de solute physiologique, et de 12,6 3,6 g lors de l'adminis-
tration d'acides aminés et de glucose. Ces résultats indiquent que Ia
perfusion intraveineuse d'acides aminés et de glucose au cours de Ia
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dialyse empéche Ia chute des acides aminés et du glucose plasmatiques
et n'occasionne qu'une diminution minime des pertes en acides aminés
libres dans le dialysat. Puisque Ia plupart des acides aminCs perfusés est
retenue, cette technique pourrait etre utilisée pendant l'hémodialyse
pour éviter une fuite nette d'acides aminés, pour minimiser Ia dissipa-
tion des reserves d'acides aminés et de glucose et pour apporter un
supplement nutritif.
Despite numerous advances in dialysis therapy, several re-
cent studies indicate that wasting and malnutrition are still
common in patients receiving hemodialysis [1—5].
In certain patients, anorexia and poor food intake may
contribute to malnutrition [1, 3, 5, 61. For this group of patients,
an efficient and safe technique of parenteral nutrition might be
used to supplement their usual diet. In prior studies amino acids
and glucose were infused near the end of or immediately after
the hemodialysis procedure [7, 81. However, this procedure
may require additional staff time and may increase the risk of
fluid overload from such infusions.
On the other hand, infusion of these nutrients throughout the
hemodialysis procedure could have the following advantages:
(1) Such infusions would not increase the time of the patient's
treatment in the dialysis facility; this would reduce the patient's
treatment time, decrease the workload of the medical staff, and
enhance the utilization of the dialysis facility. (2) The infused
amino acids and glucose could replace the losses that occurred
throughout dialysis and thereby possibly reduce the catabolic
stress from hemodialysis [9—12]. (3) Hemodialysis can remove
the water as it is infused, and, hence lower the possibility of
fluid overload from such infusions.
Despite these considerations, some physicians are reluctant
to utilize this therapy because the amino acids and glucose
infused during hemodialysis might be largely removed by
dialysis. These concerns led us to examine plasma amino acid
and glucose concentrations and amino acid losses in eight men
who were infused intravenously with 39.5 g of amino acids and
200 g of glucose throughout a hemodialysis procedure. The men
were also studied while they received an equal volume of
normal saline under the same conditions. The results indicate
that when patients were infused with amino acids and glucose
during hemodialysis, there was a modest increase in amino acid
and glucose concentrations in plasma and in the losses of free
amino acids in dialysate. However, the large preponderance of
the infused amino acids were retained, and the fall in plasma
amino acids and glucose was prevented.
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Methods
Patients. Eight clinically stable men at the Veterans Adminis-
tration Medical Center, Portland, Oregon, who had been under-
going maintenance hemodialysis for 53 months (range, 22 to
141) were studied. Mean age was 55 6 SD years. Neither the
edema-free body weight nor the predialysis serum urea nitrogen
differed on the two days of study, and the grand means of these
values on both days were 79 25 kg and 88 22 mgJlOO ml,
respectively. Causes of renal failure were chronic glomerulone-
phritis in four patients, chronic pyelonephritis in two patients,
acute cortical necrosis in one patient, and unknown in one
patient.
Procedure. Each patient was studied during two 300-mm
hemodialyses. Patients were fasted from midnight before the
study until the end of the hemodialysis treatment. During one
hemodialysis, patients received an intravenous infusion of 800
ml of normal saline. During the other dialysis, patients received
an infusion of 800 ml containing 39.5 g of crystalline free L-
amino acids (400 ml of Aminosyn® 10%, Abbott Laboratories
Hospital Products Division, North Chicago, Illinois) and 200 g
of d-glucose (400 ml of 50% glucose). The latter infusate
provided (g infused per dialysis): histidine, 1.20; isoleucine,
2.88; leucine, 3.76; lysine, 2.88 (infused as lysine acetate; the
quantity refers to free L-lysine); methionine, 1.60: phenylala-
nine, 1.76; threonine, 2.08, tryptophan, 0.64; valine, 3.20;
tyrosine, 0.18; alanine, 5.12; arginine, 3.92; proline, 3.44;
serine, 1.68; glycine, 5.12. The amino acid composition of the
infusate was confirmed by amino acid analyses. For each
patient, the order of administration of the two infusates was
determined randomly, and each of the solutions was given to
four of the patients as their first infusion.
Infusion of each solution was begun at the exact onset of the
dialysis procedure and was continued at a constant rate until the
termination of the dialysis. The solutions were infused with an
IVAC® (IVAC Corporation, La Jolla, California) pump into the
drip chamber of the venous outflow tubing from the dialyzer.
Immediately after the last blood collection, patients drank a
solution containing Polycose® (Ross Laboratories, Division of
Abbott Laboratories, Columbus, Ohio) and fruit juice to pre-
vent reactive hypoglycemia.
Patients underwent dialysis with a Travenol® 1.5 M2 hollow
fiber dialyzer (five patients) or Gambro Lundia® 1.0 M2 (one
patient) or Gambro Nova® 1.5 M2 (two patients) parallel plate
dialyzers. In a given patient, the same dialyzer was used for
both hemodialyses. Blood flow was set at 250 ml/min and was
monitored at half-hourly intervals. Dialysate flow was moni-
tored at 10 to 15 mm intervals throughout dialysis and averaged
600 50 mI/mm. Ultrafiltration at —200 to —40 mm Hg was
used in every patient. Mean ultrafiltration pressure did not
differ with the two infusions and averaged —100 50 mm Hg.
Mean weight loss during hemodialysis was not different with the
two infusions, 3.7 2.3 kg with normal saline and 3.2 1.2 kg
with amino acids and glucose. The same dialysate was em-
ployed for all studies, Renalyte® (Cobe Laboratories, Denver,
Colorado), and it was glucose-free. Its composition (mEq/liter)
was as follows: sodium, 135; chloride, 103.5; calcium, 3.5;
magnesium, 1.0; and acetate, 38.0. Dialysate potassium, (mEq/
liter), was 1.0 for 3 patients, 2.0 for 4 patients, and 3.0 for 1
patient. For each patient, the same dialysate potassium concen-
tration was used for both dialyses.
At the exact onset, midpoint (2.5 hours), and termination (5
hours) of dialysis, arterial blood was obtained from the inflow
tubing prior to entry into the dialyzer for measurement of
plasma free amino acids and serum (predialysis) or plasma (mid-
and postdialysis) glucose, urea, potassium, and phosphorus. All
dialysate outflow was collected in a small container; a dual
channel pump was used to transfer the dialysate quickly, at a
continuous rate, into either a one-gallon jug which was packed
in dry ice or into a large vat. Thus, the dialysate in the jug,
which was used for analysis of the amino acids, was frozen
within a few minutes after it left the dialyzer. Total dialysate
volume was determined by weighing both the small jug and the
vat when they were empty and after they were filled with the
dialysate.
Analyses. Plasma was deproteinized quickly for amino acid
analysis by addition of 45 mg sulfosalicylic acid per ml plasma,
and the precipitate was removed by centrifugation. Dialysate
was not deproteinized. Both dialysate and the supernatant of
plasma were quickly frozen at —20° C until analyzed. Amino
acids were measured with a Beckman l2lM Amino Acid
Analyzer (Beckman Instruments, Palo Alto, California) using a
lithium buffer system. This method does not measure trypto-
phan. Specimens were analyzed generally for amino acids
within two weeks of collection. Serum and plasma glucose, urea
nitrogen, and phosphorus were measured with a Technicon®
SMA-l2 Auto Analyzer (Tarrytown, New York). Serum and
plasma potassium were measured by a Beckman Astra 8
Analyzer (Beckman Instruments, Palo Alto, California).
Statistical analyses were carried out with the paired t test,
analysis of variance, and linear regression analysis [13]. In-
formed consent was obtained from all patients.
Results
The mean plasma amino acid levels during hemodialysis with
the infusion of either normal saline or amino acids and glucose
are shown in Table 1. In general, plasma concentrations of
individual amino acids tended to decrease during the infusion of
normal saline. The fall in individual amino acid levels was
particularly significant for many non-essential amino acids. The
sums of the essential amino acids, non-essential amino acids
and the total amino acids in plasma' each fell significantly with
dialysis during the normal saline infusion. Most of the decre-
ment in plasma amino acid concentrations occurred by mid-
dialysis. For example, total plasma amino acid levels fell by
26% at the mid-dialysis point (P < 0.01) and by 33% at the end
of the dialysis (pre versus post, P < 0.01). During the infusion
of normal saline, the magnitude of the decrease in individual
plasma amino acid values during hemodialysis (predialysis
minus postdialysis concentrations, mmoles/liter) was correlated
with the initial (predialysis) plasma values (y = O.4l> — 11.3, r
= 0.74, N = 205, P < 0.001). A similar relation was also
observed when the fall in the individual plasma amino acids by
mid-dialysis (predialysis minus mid-dialysis concentrations)
was compared to the initial values (y = — 5.9, r = 0.69, N
= 204, P < 0.001).
During the infusion of amino acids and glucose, there was an
increase in the plasma concentration of many amino acids
'For calculation of the sums of the essential, non-essential, and total
amino acids, see the legend to Table 1.
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Table 1. Pre-, mid-, and postdialysis plasma amino acids during infusion with normal saline (8 studies) or amino acids and glucose (8
studies), moles/liter
(Table 1). The change in plasma amino acid levels was related to
the composition of the infusate; the plasma values of every
amino acid which was infused tended to increase, except for
tyrosine, which was given in very low quantities, and for
histidine. In contrast, those amino acids which were not infused
tended to decrease in plasma. The sums of the essential, non-
essential, and total plasma amino acids' each rose significantly
during infusion of amino acids and glucose. Most of the rise in
plasma amino acids occurred by mid-dialysis; the increase in
total plasma amino acids was 19% by this time, P < 0.01, while
by the end of dialysis the rise in plasma total amino acids was
20% (pre versus post, P < 0.01).
The plasma amino acid levels during treatment with normal
saline versus amino acids and glucose showed few differences
at the onset of dialysis therapy (Table 1). However, plasma
concentrations of individual amino acids at mid-dialysis and the
end of dialysis were usually greater during the amino acid and
glucose infusion. Similarly, the sum of essential, non-essential
and total amino acids were each greater at mid-dialysis and at
the end of dialysis with the infusion of amino acids and glucose
as compared to normal saline (Table 1). In general, those
plasma amino acids which were not increased at mid-dialysis
and postdialysis with the former infusion were not present in
the infusate.
The free amino acids lost in the dialysate during hemodialysis
are shown in Table 2. During the infusion of amino acids and
glucose, there were significantly greater losses of most individ-
ual amino acids and of the sums of essential, non-essential, and
total amino acids. However, the total quantity of amino acids
removed with the two infusions was not markedly different, 8.2
3.1 g(range, 3.8 to 11.4 g) during the infusion of normal saline
and 12.6 3.6 g (range, 5.9 to 15.4 g) during the administration
of amino acids and glucose.
In general, those amino acids lost in the dialysate in greater
quantities during the infusion of amino acids and glucose as
compared to normal saline were present in the former infusate.
Conversely, amino acids which were not increased in dialysate
with the amino acid and glucose solution were usually not
present in the infusate. The finding that the amino acid losses
into dialysate were greatest for the amino acids which were
infused can be explained by the higher plasma concentration for
those amino acids (Table 1). Indeed, there was a direct correla-
Predialysis, Mid-dialysis, 2.5 hr Postdialysis, 5 hr
Normal Amino acids
saline and glucose
Normal
saline
Amino acids
and glucose
Normal
saline
Amino acids
and glucose
Essential
Histidine 85 12,g 84 10 67 8 89 8° 63 9 86 15°
tsoleucine 58 14 50 14°' 51 16 113 21° 53 15 121 39°
Leucine 99 26 88 20 99 30 148 25" 105 29 157 54°
Lysine 214 54g 189 28 153 29 227 32° 138 20 219 31C
Methionine 33 5 32 5g 24 5 56 8C 19 3 62 14°
Phenylalanine 57 7f 54 47 6 80 l5°' 46 7 93 15°
Threonine 114 103 147 96 78 63 189 86° 83 51 160 134b
Valine 175 41 169 4l°' 136 59 269 46° 140 43 289 59°
Total essential 835 l04 813 104c,g 655 133 1171 149° 647 115 1187 l87'
Semi-essential
Cystine 183 77e 189 65°' 104 27 88 26 68 19 51 18
Tyrosine 42 95 37 7a,c,g 30 4 16 4° 27 3 13 3C
Non-essential
Alanine 278 72e,g 264 65e,g 160 49 368 75° 129 32 405 96°
Arginine 138 20g 104 47e,g 95 16 175 36° 78 30 179 34C
Asparagine 90 29e 54 28° 60 14 41 15° 61 24 36 11b
Aspartic acid 72 30° 66 13eg 41 11 36 6 26 7 29 11
Glutamic acid 99 36 85 40 93 38 83 35 85 43 95 60
Glutatnine 468 470 l22°" 412 58 394 97 393 83 348 131
Glycine 359 227 338 135e,g 273 133 561 207C 237 59 644 178°
Ornithine 65 l3° 68 25g 44 7 61 21 42 9 56 23°
Praline 270 l38 291 93 211 60 364 101° 180 53 344 165°
Serine 43 40 61 52 35 28 89 49° 35 24 70 60"
Total non-essentiaP 1882 362 1801 362° 1424 251 2172 505° 1266 239 2206 306°
Citrulline 109 25' 101 28,g 70 13 67 15" 60 10 58 15
Taurine 80 38e,g 68 28,,c,g 56 24 51 24 44 35 45 22
1-methylhistidine 46 32 51 31 22 38 38 25 15 28 30
3-methylhistidine
Total amino acids
44 25eg
3131 547C
45 20°
3009 365d,f
25 42
2339 276
27 11
3565 564°
23
2112
11
313
20
3560
9
412°
ab,c Differs from values obtained at the same time during infusion of normal saline; P < 0.05, P < 0.01, P < 0.001, respectively.
"° Difference between predialysis and mid-dialysis values obtained during the same infusion; P < 0.05, P < 0.01, respectively.
Difference between predialysis and postdialysis values obtained during the same infusion; P < 0.05, P < 0.01, respectively.h. Difference between mid-dialysis and postdialysis values obtained during the same infusion; P < 0.05, P < 0.01, respectively.
Total essential amino acids were calculated as the sum of histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, and
valine; total non-essential amino acids were calculated as the sum of alanine, arginine, asparagine, aspartic acid, glutamic acid, glutamine, glycine,
ornithine, proline, and serine; total amino acids were also calculated as the sum of total essential and non-essential amino acids, cystine, tyrosine,
citrulline, and taurine.k Mean SD.
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Table 2. Free amino acids lost in dialysatea
Normal saline
(N = 8)
Amino acids and
glucose (N = 8)
Significantly
differentmg/TV Dialysate
Essential
Histidine 225 128 330 114 P < 0.025
Isoleucine 149 70 346 117 P < 0.01
Leucine 284 156 466 146 P < 0.05
Lysine 462 224 735 259 P < 0.01
Methionine 173 241 203 92
Phenylalanine 174 90 292 109
Threonine 333 172 643 209 P < 0.05
Valine 434 205 782 316 P < 0.025
Total essential 2306 917 3792 1201 P < 0.025
Semi-essential
Cystine 621 352 576 244
Tyrosine 109 79 78 33
Non-essential
Alanine 357 160 800 301 P < 0.005
Arginine 411 147 816 155 P < 0.001
Asparagine 234 110 201 133
Aspartic acid 95 67 96 69
Glutamic acid 269 247 273 256
Glutamine 1513 561 1737 365
Glycine 708 292 1754 596 P < 0.005
Ornithine 155 87 221 104 P < 0.05
Proline 484 226 1047 332 P < 0.005
Serine 166 113 294 86 P <0.01
Total non-essential 4576 1491 7643 1976 P < 0.005
Citrulline 246 143 263 118
Taurine 279 300 125 55
1-Methylhistidine 131 (range 0 to 248) 328 (range 0 to 659)
3-Methylhistidine
Total amino acids1'
94 (range 0 to 228)
8151 3050
130 (range 0 to 290)
12586 3564 P < 0.01
a Mean so.
1' Total amino acids were calculated as the sum of the total essential and non-essential amino acids, cystine, tyrosine, citrulline, and taurine.
tion between the plasma concentrations of individual amino
acids during dialysis and the quantity of free amino acids in
dialysate. This relationship was observed for each of the two
infusions whether the independent variable was taken as the
plasma amino acids at predialysis (amino acids and glucose r =
0.72, N 205; normal saline r = 0.52, N 204), at mid-dialysis,
(amino acids and glucose r = 0.77, N = 206; normal saline r =
0.65, N = 203), at the termination of dialysis (amino acids and
glucose r = 0.81, N 205; normal saline r = 0.67, N = 201), or
as the average of the initial, mid-dialysis, and final concentra-
tions (Fig. 1, a and b).
The changes in serum or plasma glucose, urea, potassium,
and phosphorus are shown in Table 3. During the infusion of
normal saline, plasma glucose fell in seven of eight patients (P =
NS). In contrast, during the administration of amino acids and
glucose, plasma glucose rose in all subjects (P < 0.001). The
mean plasma glucose concentrations were significantly greater
with the latter infusion as compared to normal saline both at
mid-dialysis (P < 0.01) and the end of dialysis (P < 0.01), In
four patients, postdialysis plasma glucose fell below 70 mg/100
ml (range, 59 to 63 mg/100 ml) when they received normal
saline. In contrast, during the infusion of amino acids and
glucose, postdialysis plasma glucose concentrations were nei-
ther low nor very elevated (Table 3).
Serum and plasma urea nitrogen, potassium, and phosphorus
levels each decreased significantly during both dialyses in every
subject. In a comparison between normal saline versus amino
acids and glucose, there was no difference in plasma urea
nitrogen, potassium, or phosphorus concentrations at any of the
three times of blood sampling. Similarly, the changes in urea
nitrogen, potassium, and phosphorus between predialysis and
mid-dialysis, predialysis and postdialysis, or mid-dialysis and
postdialysis were each no different during the two infusions.
Plasma potassium sometimes fell to abnormally low values
during both infusions. Postdialysis plasma potassium levels
were less than 3.0 mEq/liter in three of eight patients receiving
normal saline and in two of eight patients given amino acids and
glucose. One patient receiving each infusion had a postdialysis
plasma phosphorus level less than 2.0 mg/lOO ml.
Discussion
Our study indicates that when patients who were fasted
overnight underwent hemodialysis using glucose-free dialysate
and standard dialyzers there was a loss of about 8 g of free
amino acids into dialysate and both plasma amino acid and
glucose concentrations fell. These findings are similar to those
of earlier studies [14—181 in which patients were often fasting
and losses of free amino acids were generally reported to be 6 to
8 g per dialysis [14, 15]. When patients eat during hemodialysis,
amino acid losses rise slightly [14]. Young and Parsons reported
somewhat smaller losses during hemodialysis, equivalent to
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3
° 0 Essential amino acids,
• tyrosine, cystine
Non-essential amino
acids
140 210 280 350 420 490 560 630 700 770
Plasma amino acid concentrations, pmo/es/Iiter
70 140 210 280 350 420 490 560 630 700 770
Plasma amino acid concentrations, pmoles//iter
Fig. 1. A Amino acids and glucose solution. The figure depicts a direct
correlation between the average individual plasma-free amino acids
(mean of pre-, mid-, and postdialysis concentrations of each amino acid)
and the loss of the free amino acids during hemodialysis. Each data
point represents a value for one amino acid in a single study from one
patient. B Normal saline solution. Direct correlation between the
average individual plasma free amino acids (mean of pre-, mid-, and
postdialysis concentrations of each amino acid) and the loss of the free
amino acids during hemodialysis is shown. Each data point represents a
value for one amino acid in a single study from one patient.
about 1.0 to 8.0 g of protein [16]. However, they used a
recirculating dialysate delivery system, which may have re-
duced amino acid losses modestly, and their amino acid losses
were estimated from alpha amino nitrogen. In previous studies,
hemodialysis usually was carried out for longer periods of time
with less efficient dialyzers. Considering these differences, the
similarity in amino acid losses in the present study and in these
previous investigations is worth noting.
In the current study, when patients received an infusion
containing 39.5 g of amino acids and 200 g of d-glucose, the free
amino acid losses into dialysate were only slightly greater, 12.6
3.6 g, and the fall in plasma amino acids and glucose was
prevented. Thus, 68% of the infused amino acids were retained.
This can be seen in Table 4 where the intake and removal of
amino acids during the hemodialysis treatments are shown.
These considerations may underestimate the degree of reten-
tion because only 15 amino acids were infused and 23 amino
acids were measured in dialysate (Table 2). If the comparison
between intake and loss of amino acids is restricted to the
amino acids infused (excluding tryptophan which was not
measured in plasma or dialysate), it is apparent that (30.6 g
38.8 g) x 100 or 79% of the infused amino acids were retained.
It is not likely that much of the amino acids infused were lost
in the urine since the mean urine output in the current patients
was only 14 ml/day. Moreover, although fractional excretion of
amino acids increases in advanced renal failure [19], the abso-
lute clearance is low and therefore could not account for
substantial urinary losses even in hemodialysis patients who are
not oliguric. Finally, the plasma amino acid levels during the
study were not markedly higher during the infusion of amino
acids and glucose as compared with normal saline and did not
exceed typical postprandial values [20]. Thus, it is very unlikely
that urinary amino acid excretion would increase substantially
in hemodialysis patients during such amino acid infusions.
Because amino acids were lost even when there was no
amino acid infusion (Table 2), one may more realistically assess
the effect of the amino acid infusion on total amino acid gain by
comparing the quantity of amino acids infused with the amino
acid solution to the increment in amino acids removed by
dialysis. Thus, an additional 4.4 g of amino acids were removed
when the amino acids and glucose were infused (Table 4).
Calculated in this way, 35.1 g or 90%, (35.1 g ÷ 38.8 g) x 100, of
the infused amino acids were retained. The slight increment in
amino acid losses during the amino acid and glucose infusion
reflects the relatively modest increase in the plasma amino
acids. Indeed, with both infusions, there was a direct correla-
tion between the average plasma concentrations of individual
amino acids during each dialysis and the quantity of amino acids
lost into dialysate (Fig. 1, a and b), an observation previously
reported from this laboratory [14]. The dialysance of amino
acids will, of course, also affect the losses, although for the
amino acids evaluated in this study, the dialysance does not
vary greatly [18].
It has been suggested that dialysis may be a catabolic event,
possibly because of the losses of amino acids and glucose [9—
12]. In fact, the present study indicates that during hemodialysis
in fasting patients, not only is there a negative amino acid and
glucose balance, but there may be disruption in amino acid
pools. For example, it can be calculated that during infusion of
normal saline, 8.2 g or 54.3 mmoles of amino acids were
removed, and plasma amino acid levels fell by 1.0 0.6
mmoles/liter. If one assumes that intravascular and extracellu-
lar amino acid concentrations are identical, it can be estimated
that there was a fall in extracellular amino acids (including
intravascular) equal to 15.9 mmoles (calculated as 79 kg mean
body weight of the eight patients x 0.20 liters extracellular
fluid/kg body weight x mmoles decrease in amino acids/liter
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Table 3. Pre-, mid-, and postdialysis glucose, urea nitrogen, potassium, and phosphorus concentrations during infusion of normal saline or
amino acids and glucosea
Predialysis, 0 hr Mid-dialysis, 2.5 hr Postdialysis, 5 hr
Normal
saline
Amino acids
and glucose
Normal
saline
Amino acids
and glucose
Normal
saline
Amino acids
and glucose
Glucose, mgIlOO ml
Urea nitrogen, mg/100 ml
Potassium, mEqiliter
Phosphorus, mg/J00 ml
83 11
92 35
5.20 0.63
4.6 1.4
89 11
92 28
5.3 0.9
4.6 1.3
73 11
51 19
3.3 0.8
2.9 0.7
157 36
52 21
3.5 0.5
2.4 0.7
70 13 (59—92)
33 13 (58—16)
3.3 0.4 (2.9—4.0)
2.7 0.5 (1.7—3.3)
136 26(93—179)
38 15 (69—19)
3.1 0.5 (2.5—3.9)
2.8 0.6(1.8—3.5)
a Values in parentheses reflect the range of values.
Table 4. Amino acid balance during hemodialysis with infusion of
amino acids and glucose as compared with infusion of normal saline
Solution infused
Total quantity of free amino acids
Infused
Lost into
dialysate
gidialysis
Retained during
hemodialysis
gidialysis
(A)
(B)
(C)
Normal saline
39.5 g Amino acids and
200 g glucose
Difference in net uptake
between (A) and (B)
0
39.5
—
8.2
12.6
—
—8.2
26.9
35.1
extracellular fluid). The rest of the amino acids lost during
hemodialysis with normal saline infusion, about 38.9 mmoles,
must be derived from intracellular sites. For some amino acids,
such as isoleucine, leucine and valine, and quantity removed
may reflect a substantial proportion of the intracellular pool [21,
221. Thus, during hemodialysis with normal saline infusion, it is
possible that, in addition to the fall in extracellular amino acids,
there may be either a major disruption in intracellular free
amino acid pools, a net breakdown of protein and peptides
which replaced the intracellular amino acid losses, or a combi-
nation of these two phenomena.
A comparison of the decrement in plasma glucose with the
expected glucose losses during dialysis [101 also suggests that
most of the glucose removed during hemodialysis with normal
saline infusion was replaced by degradation of amino acids or
glycogen. Because, in our study, the infusion of amino acids
and glucose resulted in net accretion and a rise in many plasma
amino acids and glucose, it is probable that depletion of
intracellular as well as extracellular amino acids and glucose
was avoided and enhanced gluconeogenesis, glycogenolysis,
and lipolysis might have been prevented.
It is possible that ingestion of a nutritious meal during or
immediately before hemodialysis might accomplish the same
results as infusion of amino acids and glucose. However,
Grodstein and his associates recently demonstrated that gastric
emptying is impaired, even during uneventful hemodialysis in
relatively healthy patients [231. Thus, it is not clear to what
extent food intake can replace the losses of amino acids and
glucose during hemodialysis. It may be that even relatively
healthy patients who are not able to eat well during hemodialy-
sis and have uneventful dialysis treatments might benefit from
such intravenous supplements of amino acids and glucose. This
would need to be demonstrated in prospective studies.
For the wasted or malnourished patient who eats poorly, has
gastrointestinal malfunction, or catabolic stress due to intercur-
rent illness, the infusion of amino acids and glucose offers an
opportunity to supplement dietary protein and energy intake as
well as to replace the dialyzed amino acids. For example, if a 70
kg man ingested an inadequate diet providing him an average
only of 55 g/day of protein, his weekly net protein and amino
acid intake would be: (55 g protein/dayS 7 days) or 385 g per 7
days. With the infusion of amino acids and glucose, his protein
and amino acid intake would be: (55 g protein/day 7 days) +
(39.5 g amino acids/dialysis) (3 dialysis/7 days) — (4.4 g incre-
ment in amino acid losses/dialysis) (3 dialysis/7 days) = 490.3
g/week or 1.0 g/kg/day. It is recognized that the effects of daily
fluctuation in the protein and amino acid intake of such a patient
would need to be investigated. However, in our experience, the
food intake of malnourished hemodialysis patients is often
lowest on dialysis days when these supplements would be
given; these amino acid and glucose infusions may actually
decrease daily variations in nutrient intake. Such patients might
also benefit from the administration of vitamins and minerals
during hemodialysis. Moreover, because several amino acids
which were not included in the infusate were also removed
during hemodialysis (Table 2), it might be of value to infuse a
greater variety of amino acids with this procedure.
Some investigators have recommended that amino acids or
keto-acids should be infused during the last 60 to 90 mm of
hemodialysis or immediately after dialysis has ended [7], This
form of therapy may have some disadvantages in comparison to
the infusion of these nutrients throughout the dialysis proce-
dure. First, the administration of amino acids or glucose at the
end of hemodialysis would allow some degree of amino acid and
glucose depletion to occur before the infusion is started (Table
1), particularly if the patient did not eat or absorb food during
dialysis. Also, it is possible that rapid infusion of these nutrients
could be associated with undesirably high blood levels or less
efficient metabolic utilization of these nutrients and possibly
greater dialysis losses.
On the other hand, infusion of amino acids and glucose
throughout dialysis into the venous blood line leaving the
dialyzer has a number of potential advantages. First, the
dialysis patient may receive nutritional supplements several
times each week without increasing the time for treatment or for
occupancy of a bed or chair in the dialysis facility. Second,
there is no need to insert the needle or catheter into a vein with
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a high blood flow; when patients are not on dialysis this is
usually necessary so that the hypertonic solutions will not cause
thrombophlebitis. Third, such infusions should prevent deple-
tion of amino acid and glucose poois throughout the dialysis
procedure. Fourth, the water received from the infusion can be
removed during the dialysis, and the hazards of positive water
balance from such infusions can be reduced. Finally, as this
study demonstrates, most of the infused amino acids are
retained and the plasma amino acid and glucose concentrations
generally do not rise above postprandial levels [20].
It is possible that these nutrients could be administered to
patients by adding the compounds to the dialysate [24]. This is
feasible for glucose; however, as long as rather large volumes of
dialysate are used for hemodialysis, the cost of adding sufficient
amino acids to dialysate will probably exceed the expense of
intravenous administration.
When these supplemental amino acid and glucose infusions
are used, it is important to administer a carbohydrate source,
such as bread or a high carbohydrate drink, during the last 20 to
30 mm of infusion. Otherwise, reactive hypoglycemia may
occur. Previous observations (unpublished) suggest that reac-
tive hypoglycemia can occur if such a carbohydrate source is
not administered; on the other hand, we have never observed
hypoglycemia when such supplements were given.
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